Wall Street analysts expect Constellium N.V. (NYSE:CSTM) to report sales of $1.51 billion for the current quarter, according to Zacks. Five analysts have issued estimates for Constellium’s earnings, with estimates ranging from $1.43 billion to $1.54 billion. Constellium posted sales of $1.25 billion during the same quarter last year, which suggests a positive year over year growth rate of 20.8%. The company is expected to announce its next earnings report on Thursday, March 8th.

On average, analysts expect that Constellium will report full year sales of $1.51 billion for the current fiscal year, with estimates ranging from $6.13 billion to $6.21 billion. For the next fiscal year, analysts anticipate that the company will post sales of $6.55 billion per share, with estimates ranging from $6.43 billion to $6.68 billion. Zacks’ sales averages are an average based on a survey of sell-side analysts that cover Constellium.

Constellium (NYSE:CSTM) last announced its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.18 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.36 billion. Constellium had a negative return on equity of 5.81% and a net margin of 0.61%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.14 earnings per share.

CSTM has been the subject of a number of research analyst reports. BidaskClub downgraded Constellium from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 14th. Cowen set a $13.00 price objective on Constellium and gave the company a “buy” rating in a research note on Tuesday, December 12th. ValuEngine cut Constellium from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. BMO Capital Markets set a $13.00 price objective on Constellium and gave the company a “hold” rating in a research note on Friday, October 27th. Finally, Morgan Stanley upgraded Constellium from an “equal weight” rating to an “overweight” rating in a research note on Thursday, November 16th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Constellium presently has an average rating of “Hold” and an average target price of $11.67.

A number of hedge funds and other institutional investors have recently modified their holdings of CSTM. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in Constellium in the third quarter valued at approximately $5,051,000. Arrowstreet Capital Limited Partnership lifted its stake in Constellium by 1,227.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 530,944 shares of the industrial products company’s stock valued at $3,664,000 after buying an additional 490,944 shares during the last quarter. Graticule Asia Macro Advisors LLC purchased a new stake in Constellium in the third quarter valued at approximately $4,279,000. Boston Partners purchased a new stake in Constellium in the third quarter valued at approximately $3,339,000. Finally, Wells Fargo & Company MN lifted its stake in Constellium by 234.1% in the second quarter. Wells Fargo & Company MN now owns 423,259 shares of the industrial products company’s stock valued at $2,921,000 after buying an additional 296,572 shares during the last quarter. Institutional investors own 56.75% of the company’s stock.

Constellium (CSTM) opened at $11.75 on Thursday. The company has a quick ratio of 0.70, a current ratio of 1.24 and a debt-to-equity ratio of -4.43. The stock has a market capitalization of $1,580.00, a P/E ratio of 36.72 and a beta of 0.67. Constellium has a fifty-two week low of $5.35 and a fifty-two week high of $12.45.

TRADEMARK VIOLATION NOTICE: This article was originally published by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was copied illegally and republished in violation of international trademark & copyright legislation. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/01/11/zacks-brokerages-anticipate-constellium-n-v-cstm-will-announce-quarterly-sales-of-1-51-billion.html.

About Constellium

Constellium N.V. is a Netherlands-based company engaged in developing aluminum products for a range of markets and applications, including aerospace, automotive and packaging. The Company’s manufacturing facilities are located in the United States, Europe and China. It operates through three segments: Packaging & Automotive Rolled Product; Aerospace & Transportation, and Automotive Structures & Industry.

Get a free copy of the Zacks research report on Constellium (CSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.